Mycosis fungoides and Sézary syndrome: Australian clinical practice statement

Friyana K. Bhabha, Christopher McCormack, Jillian Wells, Campbell, Kate Newland, Stephen Lade, Odette Buelens, David Joske, Jake Shortt, Sally Mapp, Dejan Radeski, Mark Hertzberg, Amit Khot, Carrie Van Der Weyden, Christine Khoo, Eliza Hawkes, H. Miles Prince

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).

Original languageEnglish
Pages (from-to)e8-e18
JournalAustralasian Journal of Dermatology
Volume62
Issue number1
DOIs
Publication statusPublished - Feb 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mycosis fungoides and Sézary syndrome: Australian clinical practice statement'. Together they form a unique fingerprint.

Cite this